• Report Adverse Event or Product Quality Complaint
  • Global Site
AstraZeneca Medical Information
  • Prescribing Information
  • Resources
    • Congress Library
    • Our Pipeline
    • AZ Clinical Trials
    • Externally Sponsored Scientific Research
  • Connect
    • Send MIR
    • Give Feedback

Search Medical Information

European Alliance of Associations for Rheumatology (EULAR) - 2025

June 11 - 14, 2025

  1. SAPHNELO (anifrolumab)
  2. Lupus
  3. Benralizumab

pdf

Treatment with anifrolumab prevents long-term organ damage compared to real-world standard of care: Findings from the LASER study

pdf

Consensus-based guidance for glucocorticoid tapering in patients with systemic lupus erythematosus: results from a modified Delphi consensus project

pdf

Efficacy of two years of treatment with anti-IL-5/R therapies according to historic disease severity in patients with eosinophilic granulomatosis with polyangiitis

pdf

Efficacy of two years of treatment with anti-IL-5/R therapy for achieving glucocorticoid-free sustained remission in eosinophilic granulomatosis with polyangiitis

Need Help?

Contact Us

Send MIR

Submit a Medical Information Request

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

AstraZeneca Logo

This platform is provided as service to healthcare professionals by AstraZeneca Philippines, for medical educational purposes only.

©2024 AstraZeneca. All rights reserved.

PH-10554.

Last Updated 5/24

Contact Us

About Us

AstraZeneca.com

Survey Feedback

Privacy Notice

Legal Notice

Cookie Notice

Global Site

Report Adverse Event or Product Quality Complaint

Privacy NoticeLegal NoticeCookie Notice

Welcome to AstraZeneca Philippines Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the Philippines, for medical educational purposes only. AstraZeneca does not engage in the promotion of unregistered products or unapproved indications. The dissemination of this information may be subject to different medical and regulatory requirements in other countries

Are you a healthcare professional practicing in the Philippines?

No